Aims/hypothesis This meta-analysis assessed the pooled effect of each genetic variant
reproducibly associated with diabetic nephropathy. Methods PubMed, EMBASE and Web of …

Background A recent genome-wide association study for diabetic nephropathy in European
type 1 diabetes identified 3 candidate loci for diabetic nephropathy. In this study, we …

The development of debilitating complications represents a major heathcare burden
associated with the treatment of diabetes. Despite advances in new therapies for controlling …

Type 2 diabetes is a leading cause of morbidity and mortality. While genetic variants have
been found to influence the risk of type 2 diabetes mellitus, relatively few studies have …

OBJECTIVE Despite extensive evidence for genetic susceptibility to diabetic nephropathy,
the identification of susceptibility genes and their variants has had limited success. To …

Diabetes is one of the fastest growing diseases worldwide, projected to affect 693 million
adults by 2045. Devastating macrovascular complications (cardiovascular disease) and …

Diabetic nephropathy (DN) is associated with excess morbidity and mortality, in both type 1
(T1D) and type 2 (T2D) diabetic patients. Despite intensification of treatment, DN remains a …

OBJECTIVE—Epidemiological and family studies have demonstrated that susceptibility
genes play an important role in the etiology of diabetic nephropathy, defined as persistent …

Diabetic microvascular complications, affecting the kidneys, retina, and the nervous system,
are a heavy burden for both the diabetic individual and society. The complications seem to …

Background. Diabetic nephropathy is likely to be a complex genetic trait. To date, most
diabetic nephropathy candidate gene studies have tested a limited number of genes and …